Concepedia

Ronit Simantov

RS

Statistics

Publications

58

Citations

12.4K

H-Index

37

Active since

1982

Affiliations

Cornell University(Current)

Pfizer (United States)

Dana-Farber Cancer Institute

Bayer (United States)

University of California San Diego

Ronit Simantov is an author at Cornell University specializing in medicine, oncology, and pharmacology.

Publications per year

1982–2023

58

Publications

58

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

, , +11

Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis et al. · New England Journal of Medicine · 2003 · 1.4K citations · Full text

, , +14

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Mark J. Ratain, Tim Eisen, Walter M. Stadler et al. · Journal of Clinical Oncology · 2006 · 1K citations · Full text

, , +12

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

Tim Eisen, T. Ahmad, Keith T. Flaherty et al. · British Journal of Cancer · 2006 · 636 citations · Full text

, , +15

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

Ronit Simantov, J M LaSala, S K Lo et al. · Journal of Clinical Investigation · 1995 · 421 citations · Full text

, , +16

1–5 of 58